Skewed peripheral B- and T-cell compartments in patients with ANCA-associated vasculitis.

ANCA-associated vasculitis B-lymphocyte T-lymphocyte granulomatosis with polyangiitis (GPA) microscopic polyangiitis neutrophils

Journal

Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501

Informations de publication

Date de publication:
14 05 2021
Historique:
received: 08 12 2019
revised: 04 06 2020
pubmed: 8 10 2020
medline: 30 6 2021
entrez: 7 10 2020
Statut: ppublish

Résumé

To characterize lymphocytes dysregulation in patients with granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Using flow cytometry, we analysed B- and T-cell subsets in peripheral blood from 37 untreated patients with active disease (29 GPA and 8 MPA) and 22 healthy controls (HCs). GPA patients had increased Th2 (1.8 vs 1.0%, P = 0.02), Th9 (1.1 vs 0.2%, P = 0.0007) and Th17 (1.4 vs 0.9%, P = 0.03) cells compared with HC. Patients with MPO-ANCAs had significantly more CD21- B cells than HC or PR3-ANCA patients (6.9 vs 3.3% and 4.4%, P = 0.01). CD69 expressing B cells were significantly higher in GPA and MPA (3.0 and 5.9 vs 1.4%, P = 0.02 and P = 0.03, respectively) compared with HC, whereas B-cell activating factor-receptor expression was decreased in GPA and MPA (median fluorescence intensity ratio 11.8 and 13.7 vs 45.1 in HC, P < 0.0001 and P = 0.003, respectively). Finally, IL-6-producing B cells were increased in GPA vs HC (25.8 vs 14.9%, P < 0.0001) and decreased in MPA vs HC (4.6 vs 14.9%, P = 0.005), whereas TNF-α-producing B cells were lower in both GPA and MPA patients compared with controls (15 and 8.4 vs 30%, P = 0.01 and P = 0.006, respectively). Skewed T-cell polarization towards Th2, Th9 and Th17 responses characterizes GPA, whereas B-cell populations are dysregulated in both GPA and MPA with an activated phenotype and a decreased B-cell activating factor-receptor expression. Finally, inflammatory B cells producing IL-6 are dramatically increased in GPA, providing an additional mechanism by which rituximab could be effective.

Identifiants

pubmed: 33026090
pii: 5918817
doi: 10.1093/rheumatology/keaa432
doi:

Substances chimiques

Cytokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2157-2168

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Jonathan London (J)

INSERM U1016/CNRS UMR 8104, Institut Cochin.
Université Paris Descartes.
Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris.

Nicolas Dumoitier (N)

INSERM U1016/CNRS UMR 8104, Institut Cochin.
Université Paris Descartes.
LABEX Inflamex.
Université Paris Diderot, Paris.

Sébastien Lofek (S)

INSERM U1016/CNRS UMR 8104, Institut Cochin.

Jérémie Dion (J)

INSERM U1016/CNRS UMR 8104, Institut Cochin.
Université Paris Descartes.
Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris.

Benjamin Chaigne (B)

INSERM U1016/CNRS UMR 8104, Institut Cochin.
Université Paris Descartes.
Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris.

Julie Mocek (J)

INSERM U1016/CNRS UMR 8104, Institut Cochin.

Nathalie Thieblemont (N)

INSERM U1016/CNRS UMR 8104, Institut Cochin.
Université Paris Descartes.

Pascal Cohen (P)

Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris.

Claire Le Jeunne (C)

Université Paris Descartes.
Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris.

Loïc Guillevin (L)

Université Paris Descartes.
Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris.

Véronique Witko-Sarsat (V)

INSERM U1016/CNRS UMR 8104, Institut Cochin.
Université Paris Descartes.

Nadine Varin-Blank (N)

Université Paris XIII, UFR Santé Médecine Biologie Humaine, Bobigny.
INSERM U978, Bobigny, France.

Benjamin Terrier (B)

INSERM U1016/CNRS UMR 8104, Institut Cochin.
Université Paris Descartes.
Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris.

Luc Mouthon (L)

INSERM U1016/CNRS UMR 8104, Institut Cochin.
Université Paris Descartes.
Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes Rares d'Ile de France, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris.
LABEX Inflamex.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH